Evaluating the impact of Via Pathways (VP) on the adoption of changing treatment paradigms in metastatic hormone-sensitive prostate cancer (mHSPC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Friedland, David
  • Barry, Amanda
  • Ellis, Peter
  • Sweeney, Christopher
  • McCutcheon, Stephanie
  • Lokay, Kathleen
  • Benson, Hans
  • Krebs, Melinda

publication date

  • May 20, 2016